DuoBody® technology collaboration with Janssen

Genmab and Janssen BioTherapeutics are working together to create bispecific antibodies using Genmab’s DuoBody technology platform under a July 2012 collaboration between Genmab and Janssen Biotech, Inc.   The video below, produced by Janssen BioTherapeutics, describes the key elements that have made this a successful collaboration.